181 related articles for article (PubMed ID: 28718377)
1. Downregulation of tyrosine threonine kinase inhibits tumor growth via G2/M arrest in human endometrioid endometrial adenocarcinoma.
Zhang J; Jiang Y; Zhao Y; Wang W; Xie Y; Wang H; Yang Y
Tumour Biol; 2017 Jul; 39(7):1010428317712444. PubMed ID: 28718377
[TBL] [Abstract][Full Text] [Related]
2. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endometrial carcinoma by Kaempferol is interceded through apoptosis induction, G2/M phase cell cycle arrest, suppression of cell invasion and upregulation of m-TOR/PI3K signalling pathway.
Lei X; Guo J; Wang Y; Cui J; Feng B; Su Y; Zhao H; Yang W; Hu Y
J BUON; 2019; 24(4):1555-1561. PubMed ID: 31646808
[TBL] [Abstract][Full Text] [Related]
4. Targeted knockdown of death-associated protein kinase expression induces TRAIL-mediated apoptosis in human endometrial adenocarcinoma cells.
Bai T; Tanaka T; Yukawa K
Int J Oncol; 2010 Jul; 37(1):203-10. PubMed ID: 20514412
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of long noncoding RNA, NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma.
Li Z; Wei D; Yang C; Sun H; Lu T; Kuang D
Biomed Pharmacother; 2016 Dec; 84():244-251. PubMed ID: 27664948
[TBL] [Abstract][Full Text] [Related]
6. Biologic targets for therapeutic intervention in endometrioid endometrial adenocarcinoma and malignant mixed müllerian tumors.
Rice LW; Stone RL; Xu M; Galgano M; Stoler MH; Everett EN; Jazaeri AA
Am J Obstet Gynecol; 2006 Apr; 194(4):1119-26; discussion 1126-8. PubMed ID: 16580307
[TBL] [Abstract][Full Text] [Related]
7. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ
Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040
[TBL] [Abstract][Full Text] [Related]
8. Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility.
Martinez R; Blasina A; Hallin JF; Hu W; Rymer I; Fan J; Hoffman RL; Murphy S; Marx M; Yanochko G; Trajkovic D; Dinh D; Timofeevski S; Zhu Z; Sun P; Lappin PB; Murray BW
PLoS One; 2015; 10(9):e0138616. PubMed ID: 26398286
[TBL] [Abstract][Full Text] [Related]
9. SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression.
Liao YM; Song Y; Li YK; Du JH; Zhou Y
Cancer Gene Ther; 2020 Apr; 27(3-4):256-263. PubMed ID: 31543512
[TBL] [Abstract][Full Text] [Related]
10. Carfilzomib induces G2/M cell cycle arrest in human endometrial cancer cells via upregulation of p21
Zhou Y; Wang K; Zhen S; Wang R; Luo W
Taiwan J Obstet Gynecol; 2016 Dec; 55(6):847-851. PubMed ID: 28040131
[TBL] [Abstract][Full Text] [Related]
11. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
[TBL] [Abstract][Full Text] [Related]
12. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
Mitsuhashi A; Kiyokawa T; Sato Y; Shozu M
Cancer; 2014 Oct; 120(19):2986-95. PubMed ID: 24917306
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines.
Attias-Geva Z; Bentov I; Fishman A; Werner H; Bruchim I
Gynecol Oncol; 2011 May; 121(2):383-9. PubMed ID: 21295335
[TBL] [Abstract][Full Text] [Related]
14. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
15. LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.
Peña CG; Nakada Y; Saatcioglu HD; Aloisio GM; Cuevas I; Zhang S; Miller DS; Lea JS; Wong KK; DeBerardinis RJ; Amelio AL; Brekken RA; Castrillon DH
J Clin Invest; 2015 Nov; 125(11):4063-76. PubMed ID: 26413869
[TBL] [Abstract][Full Text] [Related]
16. GNA14 silencing suppresses the proliferation of endometrial carcinoma cells through inducing apoptosis and G
Wang J; Lv X; Xu F; Wei M; Liu C; Yang Y
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054423
[TBL] [Abstract][Full Text] [Related]
17. Lnc-NA inhibits proliferation and metastasis in endometrioid endometrial carcinoma through regulation of NR4A1.
Sun L; Zhou R; Dong J; Liu S; Jiao Y; Wang L; Hu S; He P; Liu X; Zhao X; Jiang G; Zhao Y
J Cell Mol Med; 2019 Jul; 23(7):4699-4710. PubMed ID: 31050196
[TBL] [Abstract][Full Text] [Related]
18. Possibility of Targeting Claudin-2 in Therapy for Human Endometrioid Endometrial Carcinoma.
Okada T; Konno T; Kohno T; Shimada H; Saito K; Satohisa S; Saito T; Kojima T
Reprod Sci; 2020 Nov; 27(11):2092-2103. PubMed ID: 32548807
[TBL] [Abstract][Full Text] [Related]
19. The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Oncotarget; 2016 May; 7(19):27538-51. PubMed ID: 27050373
[TBL] [Abstract][Full Text] [Related]
20. Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.
Schrauwen S; Depreeuw J; Coenegrachts L; Hermans E; Lambrechts D; Amant F
Gynecol Oncol; 2015 Jul; 138(1):165-73. PubMed ID: 25933683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
